DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 2AX Pharmaceutical Corp
03 1AstraZeneca UK Limited
04 1Catalent Micron Technologies, Inc.
05 1Cipla Ltd.
06 1DARMERICA, LLC
07 2Excella GmbH & Co. KG
08 1Hetero Labs Limited
09 1LETCO MEDICAL, LLC
10 1MEDISCA Inc.
11 1Natco Pharma Limited
12 1Pharma Source Direct, Inc.
13 1Professional Compounding Centers of America
14 1Professional Compounding Centers of America dba PCCA
15 1SUN PHARMACEUTICAL INDUSTRIES, INC.
16 1ScinoPharm Taiwan Ltd.
17 1Sichuan Xieli Pharmaceutical Co., Ltd.
18 1Synthimed Labs Private Limited
19 1Zhejiang Haizhou Pharmaceutical Co., Ltd.
20 1Zhejiang Hisun Pharmaceutical Co., Ltd.
01 4ANASTROZOLE
02 17Anastrozole
03 1anastrozole
01 2Canada
02 3China
03 6India
04 2Luxembourg
05 1Taiwan
06 5U.S.A
07 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-814
Start Marketing Date : 2007-01-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60440-2921
Start Marketing Date : 2001-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15.09kg/15.09kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7627
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1009
Start Marketing Date : 2015-08-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1160
Start Marketing Date : 2021-05-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2555
Start Marketing Date : 2015-08-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-4435
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0349
Start Marketing Date : 2024-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 61200-104
Start Marketing Date : 2015-05-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 58623-0041
Start Marketing Date : 2019-09-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Anastrozole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anastrozole, including repackagers and relabelers. The FDA regulates Anastrozole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anastrozole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anastrozole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anastrozole supplier is an individual or a company that provides Anastrozole active pharmaceutical ingredient (API) or Anastrozole finished formulations upon request. The Anastrozole suppliers may include Anastrozole API manufacturers, exporters, distributors and traders.
click here to find a list of Anastrozole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anastrozole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anastrozole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anastrozole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anastrozole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anastrozole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anastrozole suppliers with NDC on PharmaCompass.
We have 19 companies offering Anastrozole
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
